title: The Chemical and Physical Properties of Poly(ε-caprolactone) Scaffolds Functionalised with Poly(vinyl phosphonic acid-co-acrylic acid).
abstract: There is a clinical need for a synthetic alternative to bone graft substitute (BGS) derived from demineralised bone matrix. We report the electrospinning of Poly(ε-caprolactone) (PCL) to form a 3-dimensional scaffold for use as a synthetic BGS. Additionally, we have used Poly(vinyl phosphonic acid-co-acrylic acid) (PVPA) to improve bone formation. Fibres were formed using a 10% w/v PCL/acetone solution. Infrared spectroscopy confirmed that the electrospinning process had no effect on the functional groups present in the resulting structure. The electrospun scaffolds were coated with PVPA (PCL/PVPA), and characterised. The stability of the PVPA coating after immersion in culture medium was assessed over 21 days. There was rapid release of the coating until day 2, after which the coating became stable. The wettability of the PCL scaffolds improved significantly, from 123.3 ± 10.8° to 43.3 ± 1.2° after functionalisation with PVPA. The compressive strength of the PCL/PVPA scaffolds (72 MPa) was significantly higher to that of the PCL scaffold (14 MPa), and an intermediate between trabecular and cortical bone (7 MPa and 170 MPa, resp.). The study has demonstrated that the PCL/PVPA scaffold has the desired chemical and biomechanical characteristics required for a material designed to be used as a BGS.
authors.affiliation: School of Materials, The University of Manchester, Grosvenor Street, Manchester M1 7HS, UK.
authors.forename: A K
authors.initials: AK
authors.lastname: Bassi
authors.forename: J E
authors.initials: JE
authors.lastname: Gough
authors.forename: M
authors.initials: M
authors.lastname: Zakikhani
authors.forename: S
authors.initials: S
authors.lastname: Downes
references.citation: Mol Pharmacol. 2002 May;61(5):1255-62
references.pmid: 11961144
references.citation: Adv Drug Deliv Rev. 2008 Jan 14;60(2):184-98
references.pmid: 18045729
references.citation: J Biomed Mater Res B Appl Biomater. 2010 Jan;92(1):55-67
references.pmid: 19701915
references.citation: J Biomater Sci Polym Ed. 2007;18(5):609-22
references.pmid: 17550662
references.citation: Acta Orthop Scand. 1981;52(2):155-70
references.pmid: 7246093
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5413-8
references.pmid: 12686696
references.citation: J Biomed Mater Res. 2001 May;55(2):141-50
references.pmid: 11255165
references.citation: J Biol Chem. 1999 Dec 3;274(49):34967-73
references.pmid: 10574973
references.citation: Arthritis Rheum. 2001 Sep;44(9):2201-10
references.pmid: 11592386
references.citation: Bone. 1999 Jul;25(1):97-106
references.pmid: 10423031
references.citation: Chemphyschem. 2002 Mar 12;3(3):262-9
references.pmid: 12503172
references.citation: Biomaterials. 2006 Jun;27(16):3115-24
references.pmid: 16458961
references.citation: Curr Pharm Des. 2003;9(32):2643-58
references.pmid: 14529538
references.citation: Science. 2005 Nov 18;310(5751):1135-8
references.pmid: 16293749
references.citation: Adv Drug Deliv Rev. 2009 Oct 5;61(12):1065-83
references.pmid: 19646493
references.citation: Biomaterials. 2008 Mar;29(7):790-6
references.pmid: 18022226
references.citation: Science. 2002 Feb 8;295(5557):1014-7
references.pmid: 11834817
references.citation: Science. 1993 May 14;260(5110):920-6
references.pmid: 8493529
references.citation: J Tissue Eng Regen Med. 2011 Apr;5(4):253-63
references.pmid: 20661867